Navigation Links
Biopharmaceutical Companies Transform Clinical Trial Strategies for Success in Global Marketplace
Date:4/13/2013

CHAPEL HILL, N.C., April 13, 2013 /PRNewswire/ -- Pharmaceutical companies in North America and Europe have recently been faced with two major concerns: clinical costs are continuing to rise and sales are either rising a little or not at all. In emerging markets, organizations are experiencing lower clinical costs and rapidly rising sales. Although mature markets still represent a majority of sales, it is clear that emerging markets offer significant cost savings and important future sales.

While there are many advantages that come along with expanding into these emerging markets, large countries like China and India are now requiring local clinical trials to win regulatory approvals to market products in those countries. Despite these obstacles, pharmaceutical organizations must evaluate the necessity of expanding their clinical programs into emerging markets in order to cut costs and boost sales.

In order to help biopharma organizations set a strategic direction for conducting clinical trial activities in emerging regions of the world, Best Practices, LLC conducted a primary research report. The report, Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies for Pharmaceutical Success in a Global Marketplace, analyzes factors associated with outsourcing clinical trial activities – including cost, staffing, and quality – to help leadership evaluate the organization's approach to outsourcing relative to other market leaders.

Key study topics include:

  • Pharmaceutical presence in emerging markets
  • Evaluating resour
    '/>"/>

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
2. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
4. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
5. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
6. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
7. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
8. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
9. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
10. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
11. The Thousand-Year Business Model for a Modern Biopharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... -- According to a new market research report ... Cord Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, ... by MarketsandMarkets, the global Neuromodulation Market is estimated at $3.65 ... by 2020, at a CAGR of 11.2% during the forecast ... market data T ables and ...
(Date:7/2/2015)... -- The Green Exchange, Inc., the developer,s of "Loud Cannabis" ... app that connects cannabis growers directly to patients to ... that their service provides the fastest delivery on the ... half a dozen other delivery apps that have popped ... in that it connects growers directly with patients. ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 /PRNewswire/ ... acquisition of assets related to the ion channel biology ... had previously been obtained as part of Pfizer,s 2011 ... of Pfizer,s rights to the "Icagen" name and trademark. ... provide comprehensive services for ion channel and transporter drug ...
Breaking Medicine Technology:Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4
... JERUSALEM, March 24, 2011 The Procter & Gamble ... Industries Ltd. (Nasdaq: TEVA ) today announced ... partnership in consumer health care by bringing together both ... accelerate growth. (Logo: http://photos.prnewswire.com/prnh/20090115/CLTH035LOGO-a) ...
... Molecular Devices, Inc. and ChanTest Corporation, leading providers of ... have signed an agreement for Molecular Devices to distribute ... lines on a non-exclusive basis.  As part of the ... and GPCR cell lines and promote ChanTest,s cell optimization ...
Cached Medicine Technology:The Procter & Gamble Company and Teva Pharmaceutical Industries Form Consumer Health Care Partnership 2The Procter & Gamble Company and Teva Pharmaceutical Industries Form Consumer Health Care Partnership 3The Procter & Gamble Company and Teva Pharmaceutical Industries Form Consumer Health Care Partnership 4The Procter & Gamble Company and Teva Pharmaceutical Industries Form Consumer Health Care Partnership 5The Procter & Gamble Company and Teva Pharmaceutical Industries Form Consumer Health Care Partnership 6The Procter & Gamble Company and Teva Pharmaceutical Industries Form Consumer Health Care Partnership 7The Procter & Gamble Company and Teva Pharmaceutical Industries Form Consumer Health Care Partnership 8Molecular Devices, Inc. and ChanTest Corporation Sign Cell Line Distribution Agreement 2Molecular Devices, Inc. and ChanTest Corporation Sign Cell Line Distribution Agreement 3
(Date:7/2/2015)... ... July 02, 2015 , ... The ZAC Foundation, a ... swim season with important lessons on how to stay water safe with the help ... Wouldn’t Swim, authored by The ZAC Foundation co-founders, follows Zeke’s water safety journey. ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... today that it has reached an agreement to acquire eRubbermaid.com, an Internet ... distributor of Rubbermaid Commercial Products on the web today. , ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... Research (CVR) recently received nearly $4 million through five federal grants to ... vaccines and therapies against the deadly diseases. , The research will be ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. ... been retained to lead a national chief operating officer recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/2/2015)... ... 2015 , ... Evolved Ayurvedic Discoveries , Inc. (EAD ... to partner with companies that share a similar mission of providing the most ... Cannabidiol (CBD) formulations, combined with Ayurvedic herbs, are now available for wholesale, private ...
Breaking Medicine News(10 mins):Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3
... The Lorillard Tobacco,Company today issued the following statement ... House Committee on Energy and Commerce that would force ... tobacco industry., "The Lorillard Tobacco Company opposes H.R. ... tobacco. While Lorillard fully supports,reasonable federal regulation of the ...
... Mobility Helps Courageous Texas Man Fight Illness and Enjoy ... Last,December, James Matthijetz was in the process of ... could fully celebrate, the,24-year-old felt his body stiffen while ... had a brain hemorrhage and a minor stroke from ...
... April 4, 2008 The Pacific,Heart, Lung & ... products and adequate funding for research on,asbestos-related diseases. ... currently referred to as the "committee print," is ... provide meaningful funding., Public health concerns should ...
... with 2008 National Public Health Week, April,7-13, ... J. Markey (D-Mass.) and Congresswoman Hilda L. Solis,(D-Calif.) ... and Global,Warming on today,s introduction of a resolution ... relationship between public health,and global warming., The ...
... Personal interventions cut no-show rates 30%, study finds ... new studies make the case that more personal ... of low-income and minority patients getting recommended screening ... current issue of Clinical Gastroenterology and Hepatology ...
... Global Action Board of Directors brings ,hands on, approach ... direction to achieving Global Action,s mission statement, BOSTON, ... Global,Action announces today the recent addition of Robert Hernreich ... of Edwards,Colorado and Las Vegas, Nevada officially took his ...
Cached Medicine News:Health News:The SCOOTER Store Donates Power Scooter to an Uninsured Young Father Battling Cancer 2Health News:The SCOOTER Store Donates Power Scooter to an Uninsured Young Father Battling Cancer 3Health News:Pacific Heart, Lung & Blood Institute Position on Ban Asbestos Legislation 2Health News:Pacific Heart, Lung & Blood Institute Position on Ban Asbestos Legislation 3Health News:Patient Navigators Boost Colon Screens in Urban Minorities 2Health News:Global Action Board of Directors Announces Addition of Newest Member, Robert Hernreich 2
... provides fingertip ratchet disengagement allowing smooth, ratchet-free ... offers state-of-the-art quality in an instrument of ... durability. Low profile cutting tips allow access ... I instruments are available in just about ...
... The patented ratchet design provides fingertip ... ,The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ...
... The patented ratchet design provides fingertip ratchet ... Series I Instrument program offers state-of-the-art quality ... while maintaining strength and durability. Low profile ... tight joint spaces. Series I instruments are ...
... A broad selection of procedurally specific ... and allow easy access to all ... variety of approaches.,Loop Handled Graspers feature ... holds tissue firmly without tearing or ...
Medicine Products: